N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

C150H151ClF2N30O13 — CID 159414997

IUPACN-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc([C@@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2cncn2C)cc1F.Cc1ccc([C@H](CC(=O)c2ccc3cnc(Cc4ccnn4C)cc3n2)c2cncn2C)cc1F.Cc1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccccc1Oc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ncccc1CNC(=O)c1ccc2cnc(NC3CCOCC3)cc2n1.O=C(NCc1cc(Oc2ccccc2Cl)ccn1)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C27H25FN6O.C27H28FN5O2.C27H27N5O3.C26H24ClN5O3.C22H24N4O2.C21H23N5O2/c1-17-4-5-18(10-23(17)28)22(26-15-29-16-33(26)2)13-27(35)24-7-6-19-14-30-20(12-25(19)32-24)11-21-8-9-31-34(21)3;1-17-3-4-19(12-22(17)28)26(25-15-29-16-33(25)2)32-27(34)23-6-5-20-14-30-21(13-24(20)31-23)11-18-7-9-35-10-8-18;1-18-4-2-3-5-25(18)35-22-8-11-28-21(14-22)17-30-27(33)23-7-6-19-16-29-26(15-24(19)32-23)31-20-9-12-34-13-10-20;27-21-3-1-2-4-24(21)35-20-7-10-28-19(13-20)16-30-26(33)22-6-5-17-15-29-25(14-23(17)32-22)31-18-8-11-34-12-9-18;1-15-3-2-4-16(11-15)13-24-22(27)19-6-5-17-14-23-21(12-20(17)26-19)25-18-7-9-28-10-8-18;1-14-15(3-2-8-22-14)12-24-21(27)18-5-4-16-13-23-20(11-19(16)26-18)25-17-6-9-28-10-7-17/h4-10,12,14-16,22H,11,13H2,1-3H3;3-6,12-16,18,26H,7-11H2,1-2H3,(H,32,34);2-8,11,14-16,20H,9-10,12-13,17H2,1H3,(H,29,31)(H,30,33);1-7,10,13-15,18H,8-9,11-12,16H2,(H,29,31)(H,30,33);2-6,11-12,14,18H,7-10,13H2,1H3,(H,23,25)(H,24,27);2-5,8,11,13,17H,6-7,9-10,12H2,1H3,(H,23,25)(H,24,27)/t22-;26-;;;;/m01..../s1
InChIKeyLPAZBMOLYGKVMC-XCPPRMBKSA-N
MW2655.50 g/mol
LogP24.79
Rot. Bonds37

About N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide

N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (PubChem CID 159414997) has the molecular formula C150H151ClF2N30O13 and a molecular weight of 2655.50 g/mol. Its IUPAC name is N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.

Molecular Properties

Compound NameN-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
PubChem CID159414997
Molecular FormulaC150H151ClF2N30O13
Molecular Weight2655.50 g/mol
Exact Mass2653.17
IUPAC NameN-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc([C@@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2cncn2C)cc1F.Cc1ccc([C@H](CC(=O)c2ccc3cnc(Cc4ccnn4C)cc3n2)c2cncn2C)cc1F.Cc1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccccc1Oc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ncccc1CNC(=O)c1ccc2cnc(NC3CCOCC3)cc2n1.O=C(NCc1cc(Oc2ccccc2Cl)ccn1)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C27H25FN6O.C27H28FN5O2.C27H27N5O3.C26H24ClN5O3.C22H24N4O2.C21H23N5O2/c1-17-4-5-18(10-23(17)28)22(26-15-29-16-33(26)2)13-27(35)24-7-6-19-14-30-20(12-25(19)32-24)11-21-8-9-31-34(21)3;1-17-3-4-19(12-22(17)28)26(25-15-29-16-33(25)2)32-27(34)23-6-5-20-14-30-21(13-24(20)31-23)11-18-7-9-35-10-8-18;1-18-4-2-3-5-25(18)35-22-8-11-28-21(14-22)17-30-27(33)23-7-6-19-16-29-26(15-24(19)32-23)31-20-9-12-34-13-10-20;27-21-3-1-2-4-24(21)35-20-7-10-28-19(13-20)16-30-26(33)22-6-5-17-15-29-25(14-23(17)32-22)31-18-8-11-34-12-9-18;1-15-3-2-4-16(11-15)13-24-22(27)19-6-5-17-14-23-21(12-20(17)26-19)25-18-7-9-28-10-8-18;1-14-15(3-2-8-22-14)12-24-21(27)18-5-4-16-13-23-20(11-19(16)26-18)25-17-6-9-28-10-7-17/h4-10,12,14-16,22H,11,13H2,1-3H3;3-6,12-16,18,26H,7-11H2,1-2H3,(H,32,34);2-8,11,14-16,20H,9-10,12-13,17H2,1H3,(H,29,31)(H,30,33);1-7,10,13-15,18H,8-9,11-12,16H2,(H,29,31)(H,30,33);2-6,11-12,14,18H,7-10,13H2,1H3,(H,23,25)(H,24,27);2-5,8,11,13,17H,6-7,9-10,12H2,1H3,(H,23,25)(H,24,27)/t22-;26-;;;;/m01..../s1
InChIKeyLPAZBMOLYGKVMC-XCPPRMBKSA-N
XLogP24.79
TPSA522.11 Ų
H-Bond Donors9
H-Bond Acceptors38
Rotatable Bonds37
Heavy Atoms196
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002655.50
LogP ≤ 524.79
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1038

Analyze N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[7-[1-[2-[4-[2-[2-[6-chloro-8-fluoro-4-(4-propanoylpiperazin-1-yl)quinazolin-7-yl]-3-fluorophenoxy]ethyl]triazol-1-yl]ethyl]piperidin-4-yl]-5-fluoro-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione
CID 156154780
(4R)-4-[3-(3-acetyl-4-fluorophenyl)-2-pyridinyl]-1-[(2-chloro-4-pyridinyl)oxy]-5-(3,5-difluorophenyl)pentan-2-one;(4R)-4-[3-(3-acetyl-4-fluorophenyl)-2-pyridinyl]-5-(3,5-difluorophenyl)-1-[4-(ethoxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]pentan-2-one;(4R)-4-[3-(3-acetyl-4-fluorophenyl)-2-pyridinyl]-5-(3,5-difluorophenyl)-1-[4-(methylaminomethyl)-3-(trifluoromethyl)pyrazol-1-yl]pentan-2-one;7-[(4R)-5-(3,5-difluorophenyl)-4-[5-(4-methylphenyl)pyrimidin-4-yl]-2-oxopentyl]-1,5-dihydrocyclopenta[b]pyridin-2-one
CID 158027177
(3S)-3-[[6-acetyl-2-[4-(4-chloro-2-fluorophenoxy)phenyl]pyrimidin-4-yl]amino]pyrrolidin-2-one;2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-6-[[(2S)-3-oxobutan-2-yl]amino]pyrimidine-4-carboxamide;2-[6-(4-fluorophenoxy)-3-pyridinyl]-6-[[(2S)-3-oxobutan-2-yl]amino]pyrimidine-4-carboxamide;2-[4-(4-fluorophenyl)piperazin-1-yl]-6-[[(2S)-3-oxobutan-2-yl]amino]pyrimidine-4-carboxamide;6-[[(2S)-3-oxobutan-2-yl]amino]-2-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]pyrimidine-4-carboxamide
CID 158762146
bis(3-[(2,5-dimethylpyrazol-3-yl)methyl]-N-[(3S,4R)-4-(4-methoxyphenyl)-1-methylpyrrolidin-3-yl]isoquinoline-6-carboxamide);N-[(S)-(3-fluoro-4-methoxyphenyl)-(1-methylpyrazol-4-yl)methyl]-3-[[(3S,4S)-3-fluorooxan-4-yl]amino]isoquinoline-6-carboxamide;(3R)-3-(3-fluoro-4-methylphenyl)-3-[(3S)-3-fluoropyrrolidin-3-yl]-1-[3-(oxan-4-ylamino)isoquinolin-6-yl]propan-1-one;(3R)-3-(3-fluoro-4-methylphenyl)-3-[(3R)-3-fluoropyrrolidin-3-yl]-1-[3-(oxan-4-ylamino)isoquinolin-6-yl]propan-1-one;N-[(3S,4R)-4-(4-methoxyphenyl)-1-methylpyrrolidin-3-yl]-3-[(2-methylpyrazol-3-yl)methyl]isoquinoline-6-carboxamide
CID 160280963
2-(3-chloro-2-methoxy-4-pyridinyl)-4-ethoxy-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide;2-(5-chloro-2-methoxy-4-pyridinyl)-4-ethoxy-N-[3-(1H-1,2,4-triazol-5-yl)propyl]quinoline-7-carboxamide;1-[4-ethoxy-2-(4-fluoro-2-methoxyphenyl)quinolin-7-yl]-5-(1H-1,2,4-triazol-5-yl)pentan-1-one;4-ethoxy-2-(6-methyl-3-pyridinyl)-N-(3H-[1,2,4]triazolo[1,5-c]pyrimidin-4-ium-2-ylmethyl)quinoline-7-carboxamide;4-ethoxy-2-(6-methyl-3-pyridinyl)-N-[2-(1H-1,2,4-triazol-5-yl)ethyl]quinoline-7-carboxamide
CID 161817373
2-(4-chlorophenyl)-4-[(1R)-1-fluoropropyl]-N-[3-(1H-imidazol-2-yl)propyl]quinazoline-7-carboxamide;4-ethoxy-3-fluoro-2-(4-fluorophenyl)-N-[3-(2H-triazol-4-yl)propyl]quinoline-7-carboxamide;4-ethoxy-2-(2-methoxy-4-pyridinyl)-N-[3-(5-methyl-2H-triazol-4-yl)propyl]quinoline-7-carboxamide;4-ethoxy-2-(2-methyl-4-pyridinyl)-N-[3-(5-methyl-2H-triazol-4-yl)propyl]quinoline-7-carboxamide;4-ethoxy-2-(2-methyl-4-pyridinyl)-N-([1,2,4]triazolo[1,5-a]pyridin-6-ylmethyl)quinoline-7-carboxamide
CID 162153483
8-[4-[(dimethylamino)methyl]-3-fluorophenyl]-N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]pyrido[3,4-d]pyridazin-5-amine;8-(2,5-dimethylpyrazol-3-yl)-N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]pyrido[4,3-d]pyrimidin-5-amine;5-[5-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methylamino]pyrido[3,4-d]pyridazin-8-yl]-N,N,1-trimethylpyrazole-3-carboxamide;N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methyl-3,4-dihydro-1H-isoquinolin-6-yl)pyrido[3,4-d]pyridazin-5-amine;N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-[2-methyl-4-(methylaminomethyl)phenyl]pyrido[3,4-d]pyridazin-5-amine;N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methyl-4-propylphenyl)pyrido[4,3-d]pyrimidin-5-amine
CID 165081176
6-chloro-N-[(3R)-7-piperazin-1-yl-3,4-dihydro-2H-chromen-3-yl]indolizine-1-carboxamide;5,7-dimethyl-N-[(3R)-7-piperazin-1-yl-3,4-dihydro-2H-chromen-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;6-methyl-N-[(3R)-7-piperazin-1-yl-3,4-dihydro-2H-chromen-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide;7-methyl-N-[(3R)-7-piperazin-1-yl-3,4-dihydro-2H-chromen-3-yl]indolizine-1-carboxamide
CID 167641066

Frequently Asked Questions

What is the IUPAC name of N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The IUPAC name of N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide (CID 159414997) is N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide.
What is the SMILES notation for N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The canonical SMILES for N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is Cc1ccc([C@@H](NC(=O)c2ccc3cnc(CC4CCOCC4)cc3n2)c2cncn2C)cc1F.Cc1ccc([C@H](CC(=O)c2ccc3cnc(Cc4ccnn4C)cc3n2)c2cncn2C)cc1F.Cc1cccc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccccc1Oc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ncccc1CNC(=O)c1ccc2cnc(NC3CCOCC3)cc2n1.O=C(NCc1cc(Oc2ccccc2Cl)ccn1)c1ccc2cnc(NC3CCOCC3)cc2n1.
What is the InChIKey of N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
The InChIKey is LPAZBMOLYGKVMC-XCPPRMBKSA-N. The full InChI is InChI=1S/C27H25FN6O.C27H28FN5O2.C27H27N5O3.C26H24ClN5O3.C22H24N4O2.C21H23N5O2/c1-17-4-5-18(10-23(17)28)22(26-15-29-16-33(26)2)13-27(35)24-7-6-19-14-30-20(12-25(19)32-24)11-21-8-9-31-34(21)3;1-17-3-4-19(12-22(17)28)26(25-15-29-16-33(25)2)32-27(34)23-6-5-20-14-30-21(13-24(20)31-23)11-18-7-9-35-10-8-18;1-18-4-2-3-5-25(18)35-22-8-11-28-21(14-22)17-30-27(33)23-7-6-19-16-29-26(15-24(19)32-23)31-20-9-12-34-13-10-20;27-21-3-1-2-4-24(21)35-20-7-10-28-19(13-20)16-30-26(33)22-6-5-17-15-29-25(14-23(17)32-22)31-18-8-11-34-12-9-18;1-15-3-2-4-16(11-15)13-24-22(27)19-6-5-17-14-23-21(12-20(17)26-19)25-18-7-9-28-10-8-18;1-14-15(3-2-8-22-14)12-24-21(27)18-5-4-16-13-23-20(11-19(16)26-18)25-17-6-9-28-10-7-17/h4-10,12,14-16,22H,11,13H2,1-3H3;3-6,12-16,18,26H,7-11H2,1-2H3,(H,32,34);2-8,11,14-16,20H,9-10,12-13,17H2,1H3,(H,29,31)(H,30,33);1-7,10,13-15,18H,8-9,11-12,16H2,(H,29,31)(H,30,33);2-6,11-12,14,18H,7-10,13H2,1H3,(H,23,25)(H,24,27);2-5,8,11,13,17H,6-7,9-10,12H2,1H3,(H,23,25)(H,24,27)/t22-;26-;;;;/m01..../s1.
What are the key properties of N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide?
N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide has a molecular weight of 2655.50 g/mol, XLogP of 24.79, 37 rotatable bonds, 9 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-(2-chlorophenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(R)-(3-fluoro-4-methylphenyl)-(3-methylimidazol-4-yl)methyl]-7-(oxan-4-ylmethyl)-1,6-naphthyridine-2-carboxamide;(3S)-3-(3-fluoro-4-methylphenyl)-3-(3-methylimidazol-4-yl)-1-[7-[(2-methylpyrazol-3-yl)methyl]-1,6-naphthyridin-2-yl]propan-1-one;N-[[4-(2-methylphenoxy)-2-pyridinyl]methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(3-methylphenyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(2-methyl-3-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide is sourced from PubChem (CID 159414997), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).